Setanaxib (GKT137831) Ameliorates Doxorubicin-Induced Cardiotoxicity by Inhibiting the NOX1/NOX4/Reactive Oxygen Species/MAPK Pathway

• Main Authors: Hui Zheng (Author), Nannan Xu (Author), Zihao Zhang (Author), Fen Wang (Author), Jie Xiao (Author), Xiaoping Ji (Author)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Background: Doxorubicin (DOX)-induced cardiotoxicity is a highly concerning issue, and the mechanism by which DOX induces cardiotoxicity is likely to be multifactorial. NADPH oxidase (NOX) is associated with DOX-induced cardiotoxicity. Setanaxib (GKT137831), a preferential direct inhibitor of NOX1 a...